Special Clinical Preparation Sample Clauses

Special Clinical Preparation. A regular employee with special clinical preparation of not less than four (4) months approved by the Employer, and who is employed in the special service for which she is qualified, shall be paid an additional fifty dollars ($50.00) per month if she has utilized the course within four (4) years prior to employment.
Sample 1Sample 2Sample 3See All (51)
AutoNDA by SimpleDocs
Special Clinical Preparation. A regular employee with special clinical preparation of not less than four (4) months approved by the Employer, and who is employed in the special service for which she is qualified, shall be paid an additional fifty dollars ($50.00) per month if she has utilized the course within four (4) years prior to employment. Employees who are receiving a differential under this Article shall continue to receive such differential until such time as their employment terminates. Employees with a Diploma in Advanced Psychiatric Nursing shall receive an additional fifty dollars ($50.00) per month if she has utilized the course within four (4) years prior to employment.
Sample 1Sample 2Sample 3See All (13)
Special Clinical Preparation. A regular employee registered nurse with special clinical preparation of not less than six (6) months approved by the Employer is employed in the special service for which she is qualified, shall be paid an additional fifty dollars ($50.00) per month if she has utilized the course within four (4) years prior to employment.
Sample 1
Special Clinical Preparation. The Employees are entitled to special clinical preparation as defined the Collective Agreement (Xxxxxxxx X00, X0).
Sample 1

Related to Special Clinical Preparation

  • Preparatory Contract Negotiations Meetings Where operational requirements permit, the Employer will grant leave without pay to an employee to attend preparatory contract negotiations meetings.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!